| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.092 | 0.05 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.093 | 0.05 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |